Elmar R. Burchardt
Corporate Officer/Principal presso University of Witten/Herdecke
Posizioni attive di Elmar R. Burchardt
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| University of Witten/Herdecke | Corporate Officer/Principal | - | - |
Storia della carriera di Elmar R. Burchardt
Precedenti posizioni note di Elmar R. Burchardt
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| HEMOSTEMIX INC. | Direttore/Membro del Consiglio | - | 25/01/2017 |
| Amministratore Delegato | - | 25/01/2017 | |
| Presidente | 28/01/2015 | 25/01/2017 | |
| VERICEL CORPORATION | Direttore Tecnico/Scientifico/R&S | 01/07/2006 | 30/05/2010 |
TheraVitae, Inc.
 TheraVitae, Inc. BiotechnologyHealth Technology TheraVitae, Inc. developed and commercialized adult stem cell technologies. Its products were used to treat cardiovascular diseases. The company was headquartered in Toronto, Canada. | Direttore/Membro del Consiglio | 22/10/2014 | - |
| Amministratore Delegato | 22/10/2014 | - | |
Miltenyi GmbH
 Miltenyi GmbH Financial ConglomeratesFinance Miltenyi Biotec GmbH provides biotechnology products and services. The firm products include MACS sample preparation, MACS cell separation, MACS flow cytometry, MACS cell culture and stimulation and MACS molecular; research areas include immunology, stem cell research, neuroscience, and cancer research. Its clinical applications include clinical development, CliniMACS system, MACS GMP products, CryoMACS freezing products, TheraSorb, graft engineering, immunotherapy, tissue regeneration and freezing products. The company was founded by Stefan Miltenyi in 1989 and is headquartered in Teterow, Germany. | Direttore Tecnico/Scientifico/R&S | - | - |
| BAYER AG | Corporate Officer/Principal | - | - |
Formazione di Elmar R. Burchardt
| Hannover Medical School | Doctorate Degree |
Statistiche
Distribuzione geografica
| Germania | 5 |
| Canada | 3 |
| Stati Uniti | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
| Director/Board Member | 2 |
Settori
| Health Technology | 5 |
| Consumer Services | 3 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| VERICEL CORPORATION | Health Technology |
| BAYER AG | Health Technology |
| HEMOSTEMIX INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Miltenyi GmbH
Miltenyi GmbH Financial ConglomeratesFinance Miltenyi Biotec GmbH provides biotechnology products and services. The firm products include MACS sample preparation, MACS cell separation, MACS flow cytometry, MACS cell culture and stimulation and MACS molecular; research areas include immunology, stem cell research, neuroscience, and cancer research. Its clinical applications include clinical development, CliniMACS system, MACS GMP products, CryoMACS freezing products, TheraSorb, graft engineering, immunotherapy, tissue regeneration and freezing products. The company was founded by Stefan Miltenyi in 1989 and is headquartered in Teterow, Germany. | Finance |
TheraVitae, Inc.
TheraVitae, Inc. BiotechnologyHealth Technology TheraVitae, Inc. developed and commercialized adult stem cell technologies. Its products were used to treat cardiovascular diseases. The company was headquartered in Toronto, Canada. | Health Technology |
- Borsa valori
- Insiders
- Elmar R. Burchardt
- Esperienza
